The logo for AbbVie is displayed on a screen at FILE PHOTO: The logo for AbbVie is displayed on a screen at the New York Stock Exchange (NYSE) in New York City, New York, U.S., November 17, 2021. REUTERS/Andrew Kelly/File Photo Post navigation Previous: AbbVie takes $2.1 billion charge on cancer drug ahead of US price negotiation